Peptide binding motifs and specificities for HLA-DQ molecules

Immunogenetics

Volumn 50, Issue 1-2, 1999, Pages 8-15

  Baas, Andrea ^a   Gao, Xiaojiang ^b   Chelvanayagam, Gareth ^a  

^a Biology and Environment   (Australia)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Autoimmune disease; HLA DQ; Peptide binding; Peptide motifs

Indexed keywords

HLA DQ ANTIGEN;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; HISTOCOMPATIBILITY COMPLEX; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; IMMUNOGENETICS; PRIORITY JOURNAL; PROTEIN BINDING;

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; BINDING SITES; HLA-DQ ANTIGENS; HUMANS; MODELS, IMMUNOLOGICAL; PEPTIDES; POLYMORPHISM, GENETIC; PROTEIN BINDING;

EID: 0011558394     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050680     Document Type: Article

References (50)

1. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen HLA-A2. Nature 329:506-512
2. Bjorkman PJ, Parham P (1990) Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 59:253-288
3. Bjorkman PJ, Burmeister WP (1994) Structures of two classes of MHC molecules elucidated: crucial differences and similarities. Curr Opin Struct Biol 4:852-856
4. Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI (1997) Nomenclature for factors of the HLA system, 1996. Vox Sang 73:105-130
5. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39
6. Chelvanayagam G (1996) A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics 45:15-26
7. Chelvanayagam G (1997) A roadmap for HLA-DR peptide binding specificities. Human Immunol 57:61-69
8. Chelvanayagam G, Apostolopoulos V, McKenzie IFC, (1997) Milestones in the molecular structure of the major histocompatibility complex. Prot Engng 10:471-474
9. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, Strominger JL (1992) Predominantly naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764-768
10. Chicz RM, Lane WS, Robinson RA, Trucco M, Strominger JL, Gorga JC (1994) Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int Immunol 6:1639-1649
11. Cresswell P (1994) Getting peptides into MHC class II molecules. Curr Biol 4:541-543
12. Delgado JC, Hameed A, Yunis JJ, Bhol K, Rojas AI, Rehman SB, Khan AA, Ahmad M, Alper CA, Ahmed AR, Yunis EJ (1997) Pemphigus vulgaris autoantibody response is linked to HLA-DQB1*0503 in Pakistani patients. Hum Immunol 57:110-119
13. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC (1997) X-ray crystal structure of HLA-DR4 (DRA*0101,DRB1*0401) complexed with a peptide from human collagen II. Immunity 7:473-481
14. Ettinger RA, Kwok WW (1998) A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in Insulin-Dependent Diabetes Mellitus. J Immunol 160:2365-2373
15. Falk K, Rötzschke O, Stevanović S, Jung G, Rammensee H-G (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-296
16. Falk K, Rötzschke O, Stevanović S, Jung G, Rammensee H-G (1994) Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing and general rules. Immunogenetics 39:230-242
17. Fremont DH, Hendrickson WA, Marrack P, Kappler J (1996) Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001-1004
18. Fremont DH, Monnaie D, Nelson CA, Hendrickson WA, Unanue ER (1998) Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 8:305-317
19. Gao X (1992) Nucleotide sequence diversity of HLA class II genes in Australian Aborigines and populations of Asia-Oceania. PhD Thesis, Australian National University
20. Ghosh P, Amaya M, Mellins E, Wiley DC (1995) The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457-462
21. Godkin A, Friede T, Davenport M, Stevanović S, Willis A, Jewell D, Hill A, Rammensee H-G (1997) Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ32). Int Immunol 9:905-911
22. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261-1263
23. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC (1991) Identification of self peptides bound to purified HLA-B27. Nature 353:326-329
24. Johansen BH, Buus S, Vartdal F, Viken H, Eriksen JA, Thorsby E, Sollid LM (1994) Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease associated HLA-DQ(α1*0501,β1*0201) molecule. Int Immunol 6:453-461
25. Johansen BH, Vartdal F, Eriksen JA, Thorsby E, Sollid LM (1996a) Identification of a putative motif for binding of peptides to HLA-DQ2. Int Immunol 8:177-182
26. Johansen BH, Jensen T, Thorpe CJ, Vartdal F, Thorsby E, Sollid LM (1996b) Both a and β chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with the β chain residues being most influential. Immunogenetics 45:142-150
27. Kanai T, Nomura Y, Segawa M, Takagi K, Senju S, Matsushita S, Nishimura Y (1997) Immuno-suppressive peptides for a human T cell clone autoreactive to a unique acetylcholine receptor a subunit peptide presented by the disease-susceptible HLA-DQ6 in infant-onset myasthenia gravis. Hum Immunol 56:28-38
28. Kwok WW, Nepom GT, Raymond FC (1995) HLA-DQ polymorphisms are highly selective for peptide binding interactions. J Immunol 155:2468-2476
29. Kwok WW, Domeier ML, Raymond FC, Byers P, Nepom GT (1996) Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J Immunol 156:2171-2177
30. Lee C, McConnell HM (1995) A general model of invariant chain association with class II major histocompatibility complex proteins. Proc Natl Acad Sci USA 92:8269-8273
31. Matsushita S, Nishi T, Oiso M, Yamaoka K, Yone K, Kanai T, Nishimura, Y (1996) HLA-DQ-binding peptide motifs 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes. Int Immunol 8:757-764
32. Murthy VL, Stern LJ (1997) The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure 5:1385-1396
33. Newell WR, Trowsdale J, Beck S (1996) MHCDB: database of the human MHC (release 2). Immunogenetics 45:6-8
34. Rammensee H-G, Friede T, Stevanović S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41:178-228
35. Rudensky AYu, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA Jr (1991) Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622-627
36. Sanjeevi CB, Landin-Olsson M, Kockum I, Dahlquist G, Lernmark A (1995) Effects of the second HLA-DQ haplotype on the association with childhood insulin-dependent diabetes mellitus. Tissue Antigens 45:148-152
37. Scott CA, Peterson PA, Teyton L, Wilson IA (1998) Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8:319-329
38. Sidney J, Oseroff C, del Guercio M-F, Southwood S, Krieger JI, Ishioka GY, Sakaguchi K, Appella E, Sette A (1994) Definition of a DQ31-specific binding motif. J Immunol 152:4516-4525
39. Spurkland A, Celius EG, Knutsen I, Beiske A, Thorsby E, Vardtdal F (1997) The HLA-DQ(α1*0102, β1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(α1*01,β1*1501) heterodimer. Tissue Antigens 50:15-22
40. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215-221
41. Stern LJ, Wiley DC (1995) Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2:245-251
42. Townsend A, Bodmer H (1989) Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 7:601-624
43. Van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Koning F (1996) Peptide binding characteristics of the coeliac disease-associated DQ(a1*0501,b1*0201) molecule. Immunogenetics 44:246-253
44. Van de Wal Y, Kooy YMC, Drijfhout JW, Amons R, Papadopoulos GK, Koning F (1997) Unique peptide binding characteristics of the disease-associated DQ(α1*0501,β1*0201) vs the non-disease-associated DQ(α1*0201,β1*0202) molecule. Immunogenetics 46:484-492
45. Vartdal F, Johansen BH, Friede T, Thorpe CJ, Stevanović S, Eriksen JE, Sletten K, Thorsby E, Rammensee H-G, Sollid LM (1996) The peptide binding motif of the disease associated HLA-DQ(α1*0501,β1*0201) molecule. Eur J Immunol 26:2764-2772
46. Verreck FAW, van de Poel A, Termijtelen A, Amons R, Drijfhout J-W, Koning, F (1994) Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing. Eur J Immunol 24:375-379
47. Wucherpfennig KW, Strominger JL (1995) Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705
48. Zanelli E, Krco CJ, David CS (1997) Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity. J Immunol 158:3545-3551
49. Zhang C, Anderson A, DeLisi C (1998) Structural principles that govern the peptide-binding motifs of class I MHC molecules. J Mol Biol 281:929-947
50. Zinkernagel RM, Doherty PC (1974) Restriction of in vivo T cell-mediated cytotoxicity in lymphocyte choriomeningitis within a syngenetic or semiallogeneic system. Nature 248:701-702